Kevinkd123-123_123

The Companion Diagnostics Development Services Market

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

March 8, 2021

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunities

March 8, 2021

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

March 5, 2021

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

March 5, 2021

The biopharmaceutical contract manufacturing market

Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

March 4, 2021

The biopharmaceutical contract manufacturing market

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

March 4, 2021

The opportunity for AR / VR based digital marketing service

Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies

March 3, 2021

The market opportunity for AR / VR based healthcare digital marketing service

Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content

March 3, 2021

The AR / VR based digital marketing service providers in healthcare sector

Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

March 3, 2021

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.

March 3, 2021

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030- Roots Analysis

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community

March 3, 2021

The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.

February 26, 2021

endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030

So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions

February 25, 2021

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

February 23, 2021

global digital biomarkers market is projected to be worth over USD 22 billion by 2030

Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pertinent applications, are being increasingly adopted in modern healthcare practices

February 23, 2021

The antibody discovery services market is estimated to be worth around USD 6.5 billion by 2030

Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector in the pharmaceutical industry

February 22, 2021

85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare.

February 22, 2021

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms

February 22, 2021

over 100 service providers across the globe have capabilities to handle high energy / hazardous chemistry conditions

Various service providers claim to possess the required equipment for API synthesis under hazardous (high / low temperature and high / low pressure) conditions. Over time, the shift to high energy synthesis chemistries

February 18, 2021

High Energy / Hazardous Chemistry-based API manufacturing services market

Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over traditional approaches.

February 18, 2021

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs

Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers

February 18, 2021

120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services

Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment.

February 18, 2021

115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations.

February 17, 2021

The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

February 17, 2021

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

February 17, 2021

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

February 16, 2021

The diabetes monitoring devices market is projected to grow at a CAGR of 8%, claims Roots Analysis

The anticipated growth in the global diabetic patient population is likely to translate into significant rise in demand for advanced, cost-effective and more patient friendly solutions for disease monitoring

February 16, 2021

Presently, over 240 novel, patient friendly diabetes monitoring devices are available / being developed

Over time, a number of companies have developed advanced variants of the conventional blood glucose monitoring devices, which are portable, and minimally / non-invasive.

February 16, 2021

The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030”

A comparative analysis of the needs of different stakeholders (drug developers, diagnostic developers

January 29, 2021

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers

Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.

January 29, 2021

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030

The projected future opportunity is expected to be distributed across different application areas, types of analytical techniques used and various global regions

January 29, 2021

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

A discussion on various steps involved in development operations of companion diagnostics

January 29, 2021

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030"

An analysis of the big biopharma players engaged in this domain, featuring a heat map based on various parameters

January 29, 2021

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

The pipeline features drug candidates that target a wide range of biological antigens based on different antibody formats through novel mechanisms of action; more than 50% of these act by retargeting or activation of T-Cells

January 29, 2021

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

An analysis of the initiatives of big biopharma players engaged in this domain.

January 29, 2021

The Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030

An analysis of the various partnerships pertaining to non-invasive cancer diagnostics

January 28, 2021

The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%, till 2030

Presently, nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world

January 28, 2021

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis

An analysis of the various partnerships pertaining to non-invasive cancer diagnostics, which have been established between 2016 and 2019.

January 28, 2021

More than 90 companies claim to offer human factors engineering and usability testing services,

Human factors engineering and usability testing have now become an essential part of product design across almost all industries

January 28, 2021

The human factors engineering and usability testing service market is projected to grow at an annualized rate of ~14%, till 2030

Players involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and gain an advantage over competitor firms

January 28, 2021

The human factors engineering and usability testing services market for medical devices is projected

Based on the revenues generated from different services for usability testing, currently, the maximum share is expected to be generated through evaluative testing methodologies (61%), followed by generative testing methodologies (39%).

January 28, 2021

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030”

A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes

January 27, 2021

The Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030

Big pharma players have also made significant investments in this region, including establishing new facilities, expanding existing R&D centers and growing manufacturing facilities, focused on biotherapeutics

January 27, 2021

The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030

An analysis of the initiatives of big biopharma players engaged in this domain.

January 27, 2021

The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030”

A discussion on the upcoming opportunities (such as development of companion diagnostics, emerging technologies for biomarker assessment, and others) that are likely to impact the evolution of this market over the coming years

January 27, 2021

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers

Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.

January 27, 2021

Kevinkd123-123_123 · Newsroom